Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Inogen Inc reported revenue of $349M, up 3.9% year over year. Operating margin was -8.7% and net margin -6.5%, on a free-cash-flow margin of -3.9% with capital expenditure at 0.7% of revenue. Every figure is computed directly from INGN's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $349M | -8.7% | -6.5% |
| FY2024 | $336M | -12.7% | -10.7% |
| FY2023 | $316M | -34.7% | -32.5% |
| FY2022 | $377M | -22.6% | -22.2% |
| FY2021 | $358M | 2.6% | -1.8% |
How does INGN compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.